Department of Ophthalmology and Visual Sciences, John A. Moran Eye Center, University of Utah School of Medicine, Salt Lake City.
Utah Lions Eye Bank, Murray.
Curr Opin Ophthalmol. 2019 Jul;30(4):229-235. doi: 10.1097/ICU.0000000000000580.
Small-incision lenticule extraction (SMILE) has shown great promise in the treatment of myopia; however, the literature is less extensive in its hyperopic counterpart. The purpose of this review is to detail the recent advancements and outcomes of SMILE in the treatment of hyperopic eye disease.
SMILE has demonstrated similar visual outcomes, regression rates, centration ability, safety profiles, and wound healing as hyperopic laser-assisted in situ keratomileusis (LASIK). Lenticule preservation and implantation show further promise in the correction of higher degrees of hyperopia.
Based on the current literature, SMILE represents a viable surgical alternative to LASIK in the correction of hyperopia. Lenticule intrastromal keratoplasty and small-incision lenticule intrastromal keratoplasty may be able to correct severe hyperopia in patients who would not otherwise be candidates for refractive surgery.
微透镜切除术(SMILE)在治疗近视方面显示出巨大的潜力;然而,远视的相关文献则相对较少。本文的目的是详细介绍 SMILE 治疗远视眼病的最新进展和结果。
SMILE 在视觉结果、回退率、中心定位能力、安全性和伤口愈合方面与远视激光辅助原位角膜磨镶术(LASIK)相似。透镜的保存和植入在矫正更高程度远视方面显示出更大的潜力。
基于目前的文献,SMILE 代表了一种与 LASIK 相当的手术选择,可用于矫正远视。透镜间基质角膜移植术和微透镜间基质角膜移植术可能能够矫正那些不符合屈光手术条件的严重远视患者。